Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2024LeukemiaOpen Access

Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study

View Full Paper
Ask AI
Bookmark
Share

Authors

SJStefanie V. JunkAFAlisa FörsterGSGunnar Schmidt

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Junk et al. (2024) studied this question.

synapsesocial.com/papers/68e7757db6db6435876ea44fhttps://doi.org/10.1038/s41375-024-02173-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Uncovering genetic susceptibility to second malignant neoplasms in children and young adults: Findings from a tertiary oncology center in a resource-limited setting.2026
  2. 2Rare Variants Associated With Pediatric Cancer Treatment–Related Second Malignant Neoplasm Risk2025
  3. 3Characterization of Genetic Etiological Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts2026
  4. 4Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid Leukemia2025
  5. 5Abstract 6155: Germline variants in cancer susceptibility genes and subsequent neoplasm risks after childhood cancer: A pooled analysis of two large-scale cohorts2024